Denmark's Novo A/S, the holding company for the Novo Group, has further expanded its US operation with the opening of an office in San Francisco, which has recruited Heath Lukatch to join the team. Also, at Novo Nordisk's Princeton, New Jersey unit, former Novartis executive Edward Williams has joined as vice president of biopharmaceuticals, Pamela Harris has been promoted to VP of diabetes sales, managed care and government accounts south/ west, and Patrick Loustau to the like title, north/midwest.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze